Efficacy of Tumor-Infiltrating Lymphocytes Combined with IFN-α in Chinese Resected Stage III Malignant Melanoma

Figure 3

Overall survival time of Arm 1 versus Arm 2 was calculated using 27 patients in Arm 1 compared with 50 patients in Arm 2.